×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  

The Diabetes and Obesity Market Opportunity

July 6, 2023

 

Health care analysts Marshall Gordon and Brittany Henderson join Jeff Schulze to highlight new treatments for the chronic conditions of diabetes and obesity. They quantify the size of the Type 1 and Type 2 diabetes and obesity markets, discuss innovations in managing diabetes and explain how GLP-1 therapeutics developed to treat diabetes can be effective in addressing the much larger obese population.

Related Perspectives

Preparing for Improving Growth Earnings
International Growth EAFE 4Q25: We have increased our exposure to stocks with value characteristics through our structural growth bucket, mostly by expanding allocations to banks.
Enduring Fast and Furious AI Market
Large Cap Growth 4Q25: The Strategy meaningfully underperformed its benchmark, with underweights to mega cap and lower quality AI beneficiaries the main headwinds.
Large Cap Growth Monthly Update
Large Cap Growth November 2025: Technology stocks led a growth selloff in a month that saw sentiment turn decidedly negative over the near-term payoff from AI spending as well as future funding concerns.
Large Cap Growth Monthly Update
Large Cap Growth October 2025: Mega caps in the benchmark reported solid earnings results in October, with those directly involved in AI continuing to ramp up capex.
Doubling Down on AI Winners
Large Cap Growth 3Q25: We were quite active in repositioning the portfolio during the quarter, upgrading our exposure to perceived AI winners in infrastructure software.
More
  • Past performance is no guarantee of future results. Copyright © 2023 ClearBridge Investments. All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information.

more